MEDINA joins the global COVID-19 research effort looking for new therapeutics and diagnostic solutions for SARS-CoV-2.

MEDINA is a drug discovery organization and a partner site of the European research infrastructure EU-OPENSCREEN (
Leveraging our drug discovery expertise, the potential of our natural product libraries and the high throughput screening and metabolomic platforms, we have launched a new program to discover novel therapeutic solutions to address COVID-19 in collaboration with our research partners in Andalucía.
This program will permit to test the anti-viral activity of our library of bioactive natural products, develop new in vitro assays against SARS-CoV-2 to screen our natural products libraries and the identification of new diagnostic metabolomic biomarkers.